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Physicians should educate patients with sexually transmitted infections (STIs) on measures to prevent 
reinfection and should also undertake human immunodeﬁciency virus (HIV) testing after diagnosis of 
STIs.  These preventive measures are important,  but it is not known to what extent these procedures 
are followed in Japan.  We conducted a cross-sectional study to investigate the proportion of patients 
with STIs who received appropriate management from physicians,  namely recommendation of HIV 
testing,  encouragement of condom use and examination and/or treatment of sexual partners,  to eluci-
date the factors aﬀecting institution of each measure.  From a mailshot of 566 physicians,  409 (72.3ｵ) 
responded,  with 176 diagnosing an STI in 967 patients.  The proportions applying the 3 measures were 
low (recommendation of HIV testing: 27.0ｵ; encouragement of condom use: 64.8ｵ; examination of 
sexual partners: 17.5ｵ),  and were related to the sex of the patients and numbers of patients diagnosed 
by the physicians.  Female patients received better care than male patients,  particularly with respect 
to recommendation of HIV testing (odds ratio: 2.82).  Physicians who diagnosed more than 20 STI 
patients tended not to provide appropriate management.  These ﬁndings suggest the necessity for bet-
ter physician management of patients for eﬀective prevention of STIs.
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physician
exually transmitted infections (STIs) are 
amongst the most serious infections among 
adolescents in Japan [1-4].  The numbers of human 
immunodeﬁciency virus (HIV) infections and acquired 
immune deﬁciency syndrome (AIDS) patients are still 
increasing in Japan.  The 2007 Report of the Japanese 
Ministry of Health,  Labour and Welfare revealed that 
over 1,000 HIV cases and over 400 AIDS cases were 
newly notiﬁed in Japan in 2007,  and the majority 
(92.3ｵ) of these patients were male [5].
　 HIV infections are mainly transmitted by sexual 
intercourse.  In a study by Huhn GD et al.,  20ｵ of 
patients with HIV had another STI concomitantly [6].  
Furthermore,  previous studies indicated that STIs are 
associated with increased risk of HIV transmission 
[7-9].  Therefore,  STI patients should undergo HIV 
testing.  In Japanese public health centers,  free anony-
mous HIV testing is available.
　 Repeat infections with STIs are often observed 
[10,  11].  Patients are likely to be infected repeat-
edly because they have sexual intercourse with their 
sexual partners without condoms before their treat-
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ment is completed [12,  13].  Thus,  to prevent repeat 
infections,  STI patients undergoing treatment should 
be encouraged to use condoms and their sexual part-
ners should receive timely medical examination and 
appropriate treatment,  if required.  In Japan,  there 
are few specialized clinics for STIs.  STI patients are 
mainly diagnosed by physicians of 3 specialties 
(obstetrics and gynecology,  urology,  and dermatol-
ogy).  In the guideline for prevention of sexual trans-
mitted diseases formulated in 2000 and revised in 
2006 by the Health,  Labour and Welfare Ministry,  it 
was recommended that obstetricians/gynecologists and 
urologists educate their patients during consultation 
about the prevention of STIs by using condoms [14].  
Physicians have a good opportunity to educate their 
STI patients after diagnosis.  However,  there has been 
no study as to whether physicians utilize the opportu-
nity appropriately.
　 Physiciansʼ behavior and attitude in regard to STI 
prevention,  and the approximate frequency of STI 
patients they manage have been studied [15-24].  
These studies have indicated that many physicians do 
not educate patients on STI prevention.  However,  
both the actual proportion of STI patients who receive 
appropriate management from physicians,  and the 
factors which aﬀect the application of speciﬁc preven-
tive measures are unknown.  The 3 measures we deﬁne 
as appropriate for STI prevention,  which physicians 
can manage directly,  are recommendation of HIV test-
ing,  encouragement of condom use and examination 
and/or treatment of sexual partners.  The purpose of 
this study was to explore the actual proportions of STI 
patients who were oﬀered these 3 measures by physi-
cians after diagnosis,  and then to elucidate the factors 
which had an eﬀect on the rate of use of these mea-
sures by the physicians.
Materials and Methods
　 All physicians likely to diagnose STIs in hospitals 
and clinics in Okayama prefecture were identiﬁed from 
the Okayama Prefecture Medical Associationʼs mem-
bership lists for the above 3 specialties,  hospital or 
clinic websites,  and phone books published by the 
Nippon Telegraph and Telephone Corporation.  A 
questionnaire was sent to the 654 physicians individu-
ally,  asking them to report on the STI cases they 
newly diagnosed during the 5 weeks between January 
25th and February 28th,  2006.
　 We deﬁned STI patients as patients with the fol-
lowing 6 diseases: genital chlamydia trachomatis,  
gonorrhea,  genital herpes/herpes simplex virus,  con-
dyloma acuminatum/human papilloma virus,  syphilis,  
and nongonococcal nonchlamydial urethritis.  The cri-
teria for diagnosing these 6 diseases were deﬁned as 
pathogen detection or clinical presentation.  For each 
STI patient,  the following information was obtained 
from the physician: the diagnosed disease,  patient age 
and sex,  and the management of the patients by the 
physicians.  Regarding the physiciansʼ management,  
the following 3 questions were asked: whether they 
recommended HIV testing,  whether they encouraged 
condom use,  and whether they provided examination 
and/or treatment to a sexual partner of the patient.  
We used the following phrases for these measures:  
HIV testing,  condom use and examination of sexual 
partners.  In addition to the above information,  we also 
asked the physicians their age,  sex and specialties.  
The questionnaires were anonymous,  but did have the 
name of the hospital or clinic where the physician 
worked.  We requested that the physicians return data 
even if they did not diagnose any STI patients during 
the study period.  After the study period,  telephone 
interviews were conducted with the physicians who had 
not returned their questionnaires.  Fig.  1 shows the 
questionnaire used,  translated from Japanese into 
English.
　 We calculated the actual proportion of appropri-
ately managed patients for either sex.  Then we ana-
lyzed the relationship between the proportion of well-
managed patients and the factors relating to patients 
(sex,  age and diagnosed disease) and physicians (age,  
sex,  specialty,  number of patients diagnosed and 
clinical setting).  The analysis was performed using Epi 
Info ver. 3.3.2. This study was conducted after obtain-
ing approval from the Ethics Committee of Okayama 
University Graduate School of Medicine,  Dentistry 
and Pharmaceutical Sciences in September 2005.
Results
　 We sent forms to the 654 identiﬁed physicians 
(Fig.  2).  However,  51 physicians answered that they 
were not in fact specialists in obstetrics/gynecology,  
urology,  or dermatology; 13 physicians had been 
trans ferred; and 24 physicians had already retired or 
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died.  Therefore,  a total of 566 physicians (215 
obstetricians and gynecologists,  136 urologists,  143 
dermatologists,  and 72 general practitioners who also 
accepted dermatological cases) received forms for 
participation in this study.
　 Of the 566 physicians,  157 did not respond,  
including 59 obstetricians and gynecologists,  52 urol-
ogists and 46 dermatologists.  Therefore,  a total of 
409 physicians responded,  a rate of 72.3ｵ.  Among 
these,  309 physicians responded by mail,  and 100 
physicians responded by telephone interview.  There 
were 156 obstetricians and gynecologists with a res-
ponse rate of 74.2ｵ,  84 urologists with a response 
rate of 61.8ｵ,  and 169 dermatologists and general 
practitioners with a response rate of 78.0ｵ.
　 One hundred and seventy-six of the 409 physicians 
(43.0ｵ) diagnosed patients with one or more STIs 
during the 5 weeks (Table 1).  Of these,  107 (60.8ｵ) 
were obstetricians and gynecologists and 145 (82.4ｵ) 
were male physicians.  More than half were in their 
40s and 50s.  The proportion of physicians who diag-
nosed less than 4 STI patients was 63.6ｵ.  On the 
other hand,  the proportion of physicians who diag-
nosed more than 20 STI patients was 6.3ｵ.
　 During the 5 weeks,  453 male patients and 514 
female patients were diagnosed with one or more 
STIs (Table 2).  In regard to the relationship between 
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Male Recommended Encouraged Provided
Female Not recommended Not encouraged Not provided
Male Recommended Encouraged Provided
Female Not recommended Not encouraged Not provided
Male Recommended Encouraged Provided
Female Not recommended Not encouraged Not provided
Male Recommended Encouraged Provided
Female Not recommended Not encouraged Not provided
Male Recommended Encouraged Provided
Female Not recommended Not encouraged Not provided
Male Recommended Encouraged Provided
Female Not recommended Not encouraged Not provided
Male Recommended Encouraged Provided
Female Not recommended Not encouraged Not provided
6
5
4
3
2
1
Example
gonorrhea,  genital chlamydia trachomatis,
condyloma acuminatum,  genital herpes, syphilis,
nongonococcal nonchlamydial urethritis
gonorrhea,  genital chlamydia trachomatis,
condyloma acuminatum,  genital herpes, syphilis,
nongonococcal nonchlamydial urethritis
gonorrhea,  genital chlamydia trachomatis,
condyloma acuminatum,  genital herpes, syphilis,
nongonococcal nonchlamydial urethritis
gonorrhea,  genital chlamydia trachomatis,
condyloma acuminatum,  genital herpes, syphilis,
nongonococcal nonchlamydial urethritis
gonorrhea,  genital chlamydia trachomatis,
condyloma acuminatum,  genital herpes, syphilis,
nongonococcal nonchlamydial urethritis
gonorrhea,  genital chlamydia trachomatis,
condyloma acuminatum,  genital herpes, syphilis,
nongonococcal nonchlamydial urethritis
gonorrhea,  genital chlamydia trachomatis,
condyloma acuminatum,  genital herpes, syphilis,
nongonococcal nonchlamydial urethritis
y.o.
y.o.
y.o.
y.o.
y.o.
y.o.
24 y.o.
Examination and/or
treatment of sexual 
partner
Condom useHIV testingAge of patientSex of patientDiagnosesNo. ofpatient
Fig. 1　 Participating physicians submitted this questionnaire.
654 were sent forms
566 received forms
409 responded
51 did not have specialties＊
13 had been transferred
24 had retired or died
157 did not respond
59 Obstetricians and gynecologists
52 Urologists
46 Dermatologists
176 diagnosed STI patients
(107 obstetricians and gynecologists, 48 urologists, and 21 dermatologists)
233 did not diagnose any STI patients
＊Obstetrics/gynecology, urology, and dermatology
Fig. 2　 Selection process for the 176 physicians whose answers 
we analyzed.
the sex of the patients and the specialties of the physi-
cians,  97.7ｵ of female patients consulted an obstetri-
cian or gynecologist while 84.5ｵ of male patients 
consulted a urologist.
　 Among the physicians who provided the numbers of 
patients they diagnosed with an STI,  some did not 
inform us of their management of these patients.  As a 
result,  we did not acquire 16.8ｵ (76 among 453,  HIV 
testing),  21.6ｵ (101 among 453,  condom use),  and 
22.3ｵ (98 among 453,  examination of sexual part-
ners) of answers about male patients,  and 4.5ｵ (26 
among 517,  HIV testing),  6.0ｵ (36 among 517,  con-
dom use) and 6.4ｵ (34 among 517,  examination of 
sexual partners) of answers about female patients.
　 Of the 3 preventive measures provided by the 
physicians,  the one most frequently performed was 
encouragement of condom use,  which was made in 
64.8ｵ,  of cases (Table 3).  The proportions of 
patients who received a recommendation of HIV test-
ing and examination of sexual partners were very low.  
When stratiﬁed by sex of patients,  the proportions of 
male patients who received the appropriate measures 
were lower than those of female patients on all 3 
counts (Table 3).  On condom use and HIV testing,  the 
proportions of female patients were signiﬁcantly 
higher than male patients (Table 3,  odds ratios: 1.50 
(95ｵ conﬁdence interval (CI): 1.12-2.02) and 2.82 
(95ｵ CI: 2.00-3.98),  respectively).  The results of 
the analyses of the 3 measures are shown in Tables 4,  
5 and 6.  We also analyzed the relationship between 
patient management and the factors listed in Table 1,  
such as age and sex of physicians and clinical setting.  
Female patients who were diagnosed by female physi-
cians aged 40 or over were signiﬁcantly less likely to 
be recommended HIV testing or to be encouraged 
condom use than those diagnosed by female physicians 
aged under 40 (odds ratios: 0.06 (95ｵ conﬁdence 
interval (CI): 0.02-0.21) and 0.33 (95ｵ CI: 0.12-
0.88),  respectively).  Other than these relations,  there 
were no consistent tendencies across the 3 measures.  
The specialty of the physician was strongly correlated 
with the sex of patients.  Thus,  in the analysis we used 
the sex of the patient as a factor rather than the spe-
cialty of the physician.
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Table 1　 Characteristics of physicians＊ who diagnosed sexually transmitted infection (STI) patients
Specialty of physician
n Obstetrics/Gynecology Urology Dermatology
Total 176 107 48 21
Sex
 Male 145  83 47 15
 Female  24  17  1 6
 Unknown 　7 　7  0 0
Age (years)
 ＜40  30  16 11 3
 40-59  95  59 26 10
 ｧ60  37  25  8 4
 Unknown  14 　7  3 4
Practice Setting
 Clinic  83  56 17 10
 Hospital  93  51 31 11
Number of physicianʼs diagnoses in 5 weeks
 1-4 112  65 29 18
 5-9  32  22  8 2
 10-19  21  17  4 0
 ｧ20  11 　3  7 1
＊Physicians who diagnosed STI patients during 5 weeks (Jan 25th-Feb 28th 2006).
　 As for HIV testing,  there was no signiﬁcant rela-
tionship between age of the patients and the rate of 
recommendation of testing (Table 4).  Regarding the 
number of patients diagnosed per physician,  the physi-
cians who diagnosed 10-19 patients during the 5 
weeks were most likely to recommend HIV testing to 
male patients (Table 4).
　 As for examination of sexual partners,  teenage 
patients,  both male and female,  were less likely to be 
provided with this measure than older patients.  
Physicians who diagnosed 10-19 patients during the 5 
weeks were most likely to provide an examination of 
sexual partners (Table 5).
　 As for condom use,  teenage female patients were 
more likely to be encouraged to use condoms than 
older patients (Table 6).  Physicians who diagnosed 
more than 20 patients during the 5 weeks were least 
likely to encourage condom use (Table 6).
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Table 2　 Characteristics of STI patients
Male Percent Female Percent
Number of patients 453 514
Age of patients (years)＊ 33.1±11.4 27.0±10.2
Disease
　Chlamydia 157 34.7 323 62.8
　Gonorrhea 150 33.1  56 10.9
　Genital herpes/HSV  44  9.7  72 14.0
　Condyloma acuminatum/HPV  48 10.6  66 12.8
　Syphilis 　4  0.9 　4 0.8
　NGNCU  96 21.2 　6 1.2
Specialty of physicians who diagnosed patients
　Obstetrics/Gynecology  19  4.1 502 97.7
　Urology 383 84.6 　9 1.8
　Dermatology  51 11.3 　3 0.6
＊Mean±SD
NGNCU,  Nongonococcal nonchlamydial urethritis; HSV,  herpes simplex virus; HPV,  human papilloma virus.
Table 3　 Number and proportion of STI patients who received appropriate management by physicians, and female/male odds ratios
Condom use＊ Examination of sexual partners＊＊ HIV testing＊＊＊
N† n‡ (%) OR§ 95% CI¶ N† n‡ (%) OR§ 95% CI¶ N† n‡ (%) OR§ 95% CI¶
Total 838 543 (64.8) 833 146 (17.5) 868 234 (27.0)
Sex of patients
 Male 355 211 (59.4) 1.00 352  52 (14.8) 1.00 377  61 (16.2) 1.00
 Specialty of physicians♯
　Obstetrics/Gynecology  19  13 (68.4)  19  17 (89.5)  19  11 (57.9)
　Urology 310 188 (60.6) 305  32 (10.5) 309  44 (14.2)
　Others  16  10 (62.5)  28 　3 (10.7)  48 　6 (12.5)
 Female 483 332 (68.7) 1.50 1.12-2.02 481  94 (19.5) 1.40 0.95-2.07 491 173 (35.2) 2.82 2.00-3.98
 Specialty of physicians♯
　Obstetrics/gynecology 472 328 (69.5) 470  91 (19.4) 480 171 (35.6)
　Urology 　9 　3 (33.3) 　9 　3 (33.3) 　9 　1 (11.1)
　Others 　2 　1 (50.0) 　2 　0 (0.0) 　2 　1 (50.0)
＊Encouragement of condom use,  ＊＊Providing sexual partnerʼs examination and/or treatment,  ＊＊＊Recommendation of HIV testing,  
†Number of patients,  ‡Number of patients who received appropriate management,  ♯Specialty of physicians who diagnosed the STI patients,  §Odds ratio,  ¶95% 
conﬁdence interval.
　 There was no signiﬁcant relationship between the 
type of disease and the proportion of each measure 
except for examination of sexual partners among male 
patients.  Patients with co-infections were not managed 
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Table 4　 Number and proportion of STI patients for whom HIV testing was recommended,  stratiﬁed by age of patients and number of 
physicianʼs diagnoses during the investigation
HIV testing Male patients Female patients
N† n‡ (%) OR§ 95% CI¶ N† n‡ (%) OR§ 95% CI¶
Total 377 61 (16.2) 491 173 (35.2)
Age of patients (years)
 ＜20  17 　3 (17.6) 1.00  82  33 (40.2) 1.00
 20-29 139  21 (15.1) 0.83 0.20-4.00 267  90 (33.7) 0.76 0.44-1.30
 ｧ30 201  37 (18.4) 1.05 0.26-4.88 142  50 (35.2) 0.81 0.44-1.47
Disease
　Chlamydia (single) 100  25 (25.0) 1.00 293 112 (38.2) 1.00
　Gonorrhea (single) 103  15 (14.6) 0.51 0.24-1.10  39  13 (33.3) 0.81 0.38-1.72
　Chlamydia＋Gonorrhea (co-infection)  19 　3 (15.8) 0.56 0.12-2.31  16 　5 (31.3) 0.73 0.22-2.36
Number of physicianʼs diagnoses in 5 weeks
 1-4  80  13 (16.3) 2.01 0.86-4.71 115  33 (28.7) 0.67 0.35-1.29
 5-9  62 　7 (11.3) 1.32 0.46-3.64 140  51 (36.4) 0.96 0.52-1.76
 10-19  53  25 (47.2) 9.26 4.14-20.93 156  59 (37.8) 1.01 0.56-1.84
 ｧ20 182  16 (8.8) 1.00  80  30 (37.5) 1.00
†Number of patients,  ‡Number of patients who were recommended HIV testing,  §Odds ratio,  ¶95% conﬁdence interval.
Table 5　 Number and proportion of STI patients with examination and/or treatment of sexual partners,  stratiﬁed by age of patients and 
number of physicianʼs diagnoses during the investigation
Examination of partners Male patients Female patients
N† n‡ (%) OR§ 95% CI¶ N† n‡ (%) OR§ 95% CI¶
Total 352 52 (14.8) 481 94 (19.5)
Age of patients (years)
 ＜20  16 　2 (12.5)  1.00  81 10 (12.3) 1.00
 20-29 138  21 (15.2)  1.26 0.24-8.64 261 46 (17.6) 1.52 0.70-3.40
 ≧30 198  29 (14.6)  1.20 0.24-8.09 149 38 (25.5) 2.67 1.19-6.15
Disease
　Chlamydia (single)  87  30 (34.5)  1.00 285 70 (24.6) 1.00
　Gonorrhea (single)  94  11 (11.7)  0.25 0.11-0.58  39  9 (23.1) 0.92 0.39-2.15
　Chlamydia＋Gonorrhea (co-infection)  18 　0 (0.0)  16  4 (25.0) 1.02 0.27-2.36
Number of physicianʼs diagnoses in 5 weeks
 1-4  80  13 (16.3) 15.23  3.14-100.64 111 14 (12.6) 0.46 0.20-1.06
 5-9  60  13 (21.7) 27.58  5.55-185.50 140 17 (12.1) 0.44 0.20-0.97
 10-19  53  24 (45.3) 64.97 13.71-421.78 150 44 (29.3) 1.33 0.68-2.61
 ｧ20 159 　2 (1.3)  1.00  80 19 (23.8) 1.00
†Number of patients,  ‡Number of patients provided with examination of sexual partners,  §Odds ratio,  ¶95% conﬁdence interval.
more carefully than patients with single infections.
　 For male patients,  the rate of implementation of 
the 3 measures decreased in the physicians who diag-
nosed more than 20 patients.  The same tendency was 
observed in female patients for encouragement of 
condom use,  but not for recommendation of HIV test-
ing or examination of sexual partners.
Discussion
　 This study found that physicians provided appro-
priate management to only a small proportion of STI 
patients.  The rates of implementation of each measure 
varied depending on the sex of the patients and the 
numbers of STI patients diagnosed per physician.  The 
low proportion of patients who received appropriate 
management (Table 3) agrees with the result of a 
previous study which indicated low rates of recom-
mendation of HIV testing and education on condom use 
by physicians [15].  The low proportion of patients 
who received examination or treatment of sexual 
partners (Table 3) also agrees with the results of a 
previous study for urologists [24,  25].  From the 
results of the analysis,  there was no consistent ten-
dency between patient factors and each measure 
instituted by the physicians,  except for the sex of 
patients.  Thus it is important to increase the rates of 
application of the 3 measures in male patients in par-
ticular.
　 The reason for the low proportion of management 
from physicians who diagnosed more than 20 STI 
patients during the investigation (Tables 4,  5,  6) is 
unclear.  However,  the impact of these physicians is 
substantial.  That is,  it is particularly desirable that 
physicians who see many patients provide appropriate 
management.  The low proportion of patients who were 
recommended HIV testing by these physicians was 
likely a result of the cumbersome protocol for con-
ducting HIV testing.  In most cases,  physicians must 
follow a relatively involved procedure for obtaining 
informed consent before HIV testing [26].  Further-
more,  they need more time for consultation if the test 
result is positive.  Potential solutions to this problem 
include providing patients with an explanatory leaﬂet 
in a medical setting or eﬀectively utilizing social 
resources such as free HIV testing at public health 
centers.  The usefulness and acceptability of using a 
leaﬂet for discussion before HIV testing have been 
shown in the previous study [27].  In addition,  it is 
necessary to give physicians more information about 
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Table 6　 Number and proportion of STI patients for whom condom use was encouraged,  stratiﬁed by age of patients and number of 
physicianʼs diagnoses during the investigation
Condom use Male patients Female patients
N† n‡ (%) OR§ 95% CI¶ N† n‡ (%) OR§ 95% CI¶
Total 355 211 (59.4) 483 332 (68.7)
Age of patients (years)
 ＜20  17  11 (64.7) 1.00  83  67 (80.7)  1.00
 20-29 138  86 (62.3)  0.9 0.28-2.85 262 176 (67.2)  0.49 0.26-0.93
 ｧ30 200 114 (57.0) 0.72 0.23-2.22 138  89 (64.5)  0.43 0.22-0.87
Disease
　Chlamydia (single)  88  55 (62.5) 1.00 288 208 (72.2)  1.00
　Gonorrhea (single)  96  66 (68.8) 1.32 0.69-2.54  39  29 (74.4)  1.12 0.49-2.57
　Chlamydia＋Gonorrhea (co-infection)  19 　5 (26.3) 1.08 0.35-3.55  16  11 (68.8)  0.85 0.26-2.89
Number of physicianʼs diagnoses in 5 weeks
 1-4  80  50 (62.5) 1.84 1.03-3.30 115  85 (73.9)  7.47 3.75-15.02
 5-9  60  39 (65.0) 2.05 1.06-3.97 139 111 (79.9) 10.45 5.25-21.00
 10-19  53  45 (84.9) 6.21 2.61-15.28 149 114 (76.5)  8.59 4.43-16.80
 ｧ20 162  77 (47.5) 1.00  80  22 (27.5)  1.00
†Number of patients,  ‡Number of patients provided with examination of partners,  §Odds ratio,  ¶95% conﬁdence interval.
free HIV testing at public health centers because most 
of them do not know the dates and times of testing 
[28].
　 Although STI patients are a high-risk group for 
HIV,  the proportion of STI patients who were recom-
mended HIV testing was low among not only male but 
also female patients in this study.  This indicated that 
HIV testing during STI treatment has not been a com-
mon practice in Japan.  In the guideline for diagnosis 
and treatment of STIs published by the Japanese 
Society for Sexually Transmitted Infections,  it is 
mentioned that physicians need to oﬀer HIV testing to 
all syphilis patients,  but HIV testing for patients with 
other STIs is not mentioned particularly [29].  This 
is considered to be one of the reasons why only a small 
population of patients was recommended HIV testing 
in the present study.  In contrast,  in the United 
States,  it is stipulated in the STIs treatment guide-
line published by the CDC (Centers for Disease 
Control and Prevention) that all persons who seek 
evaluation and treatment for STIs should be screened 
for HIV infection regardless of whether the patient is 
known or suspected to have speciﬁc behavioral risks 
for HIV infection [26].  The CDC also recommended 
HIV testing as a routine part of medical care for all 
patients aged 13 to 64 in health care settings,  because 
they estimated that a quarter of HIV-positive subjects 
have not been diagnosed [30].
　 This study suggested that only a low proportion of 
male patients are recommended for HIV testing.  This 
is a particularly important ﬁnding because,  in Japan,  
more than 90ｵ of HIV-positive and AIDS patients are 
male,  and most new cases are infected by sexual 
intercourse [5].  Adding a mention about the impor-
tance of HIV testing for male STI patients in the 
Japanese guideline could increase HIV testing for male 
patients.  However,  although awareness of this guide-
line is high,  with about 80ｵ of physicians having 
general knowledge of the publication,  only half of 
physicians follow the guideline when treating their STI 
patients [24,  25].  Thus,  in addition to adjusting the 
contents,  the guideline must be further disseminated.
　 Regarding the low rate of examination or treat-
ment of male patientsʼ sexual partners,  some urolo-
gists commented to us that it is diﬃcult to examine or 
treat sexual partners of male STI patients because 
their sexual partners are often unspeciﬁed.  In such 
cases,  however,  physicians should still endeavor to 
examine or treat close partners.
　 Our study has several limitations.  First,  we may 
not have received responses from physicians who 
diagnose a large number of STI cases,  because 
27.7ｵ (157 among 566) of physicians did not respond.  
If so,  we might have underestimated the impact of the 
physicians who diagnose a large number of patients.  
Second,  we did not receive approximately 20ｵ of 
answers about the management of male patients,  com-
pared with only 5ｵ of answers about females.  The 
reason for this is that the urologist who diagnosed 55 
patients did not respond about his patient manage-
ment.  We might have overestimated the proportion of 
male patients who received appropriate management 
because physicians who saw more than 20 patients 
tended not to manage patients well,  and did not 
respond in this study.  However,  the tendency in the 
present study for male patients to receive less appro-
priate management than females would still be valid 
even if the urologist did not provide appropriate man-
agement to many male patients.  Third,  each physician 
who saw more than 20 patients during the study had a 
marked inﬂuence on the proportion of patients who 
received appropriate management.  Therefore,  we 
might have underestimated those proportions if the 
physicians who provided appropriate management did 
not respond to our survey.  Fourth,  we could not 
exclude the patients who visited obstetricians and 
gynecologists for pregnancy,  for which HIV testing is 
routine.  Therefore,  HIV tests which were not done 
after diagnoses of STIs for pregnant women may be 
included.  In those cases,  we may have overestimated 
the proportion of female patients who were recom-
mended for HIV testing by obstetricians and gynecolo-
gists.  This may account for the higher proportion of 
female patients who were recommended for an HIV 
test.
　 In summary,  the proportion of STI patients who 
received appropriate physician management other than 
treatment of the diagnosed STI (recommendation of 
HIV testing,  examination of sexual partners and edu-
cation regarding condom use) was very low,  and was 
lower for male patients than female patients.  In par-
ticular,  it is necessary to increase the proportion of 
male patients who are given appropriate management.  
In addition,  physicians who saw many patients tended 
not to provide appropriate management.  Our results 
indicate that a number of measures,  as discussed 
178 Acta Med.  Okayama　Vol.  64,  No.  3Kodama et al.
above,  should be implemented to improve the manage-
ment of these cases.
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